Breaking Ground in Recurrent or Metastatic Head and NeckSquamous Cell Carcinoma: NovelTherapies Beyond PD-L1ImmunotherapyClearly no one is happy about the fall from 42 to 35 in a week.
but it’s important to remember that ASCO abstracts including late breakers are out next week (24th).
Also there’s head and neck cancer sessions at ASCO on 3 June - including “breaking ground in HNSCC: novel therapies beyond PD-1 immunotherapy”.
Media, page-733
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.025(5.95%) |
Mkt cap ! $562.6M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 39.5¢ | $1.293M | 3.198M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 245115 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 41012 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |